Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors

類似資料

• The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas
  著者:: Suzuki, Michio, 等
  出版事項: (2015)
• The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor Models
  著者:: Smyth, Tomoko, 等
  出版事項: (2012)
• Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance
  著者:: Li, Min, 等
  出版事項: (2013)
• Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
  著者:: George, Suzanne, 等
  出版事項: (2009)
• BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins
  著者:: LIN, SHENGYUN, 等
  出版事項: (2014)